Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
Teva
Argus Health
Federal Trade Commission
Fish and Richardson
Citi
Accenture
Chinese Patent Office
Chubb

Generated: February 18, 2018

DrugPatentWatch Database Preview

NORCURON Drug Profile

« Back to Dashboard

When do Norcuron patents expire, and when can generic versions of Norcuron launch?

Norcuron is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in NORCURON is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
Drug patent expirations by year for NORCURON
Medical Subject Heading (MeSH) Categories for NORCURON

US Patents and Regulatory Information for NORCURON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NORCURON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-002 Apr 30, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Organon Usa Inc NORCURON vecuronium bromide INJECTABLE;INJECTION 018776-003 Jan 3, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Teva
Chubb
Cipla
Baxter
Boehringer Ingelheim
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot